The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Neuropathic low back pain in clinical practice
Open accessAbstract
Background and objective: Low back pain (LBP) is one of the most common chronic pain conditions. This paper reviews the available literature on the role of neuropathic mechanisms in chronic LBP and discusses implications for its clinical management, with a particular focus on pharmacological treatments. Databases and data treatment: Literature searches were performed in PubMed, key pain congresses and ProQuest Dialog to identify published evidence on neuropathic back pain and its management. All titles were assessed for relevant literature. Results: Chronic LBP comprises both nociceptive and neuropathic components, however, the neuropathic component appears under‐recognized and undertreated. Neuropathic pain (NP) is challenging to manage. Many patients with chronic LBP have pain that is refractory to existing treatments. Typically, less than half of patients experience clinically meaningful analgesia with oral pharmacotherapies; these are also associated with risks of adverse effects. Paracetamol and NSAID s, although widely used for LBP, are unlikely to ameliorate the neuropathic component and data on the use of NP medications such as antidepressants and gabapentin/pregabalin are limited. While there is an unmet need for improved treatment options, recent data have shown tapentadol to have efficacy in the neuropathic component of LBP, and studies suggest that the capsaicin 8% patch and lidocaine 5% medicated plaster, topical analgesics available for the treatment of peripheral NP, may be a valuable additional approach for the management of neuropathic LBP. Conclusions: Chronic LBP often has an under‐recognized neuropathic component, which can be challenging to manage, and requires improved understanding and better diagnosis and treatment. What does this review add?: Increased recognition and improved understanding of the neuropathic component of low back pain raises the potential for the development of mechanism‐based therapies. Open and retrospective studies suggest that agents like tapentadol and topical analgesics — such as the capsaicin 8% patch and the lidocaine 5% medicated plaster — may be effective options for the treatment of neuropathic low back pain in defined patient groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888 · cited 1×
“Results of the 2010 Global Burden of Disease Study show LBP to be the most common cause of years lived with disability (YLDs) and the sixth leading cause of disability-adjusted life-years (DALYs) worldwide (Murray et al., 2012; Vos et al., 2012).”
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Fairbank, J. C. T., & Pynsent, P. B. (2000) · Spine · doi:10.1097/00007632-200011150-00017 · Cited by 5,851
Persistent postsurgical pain: risk factors and prevention
Kehlet, H., Jensen, T. S., & Woolf, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68700-x · Cited by 4,086
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980 · cited 3×
“The substantial lack of a routine approach to the diagnosis of pain is further highlighted by the results of a recent study undertaken in a rehabilitation setting, where LBP is a major clinical problem (Casale et al., 2012).”
BackgroundResultSelf-citationTreede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Chou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718
Chapter 4 European guidelines for the management of chronic nonspecific low back pain
Airaksinen, O., Brox, J. I., Cedraschi, C., Hildebrandt, J., Klaber-Moffett, J., Kovacs, F., Mannion, A. F., Reis, S., Staal, J. B., Ursin, H., et al. (2006) · European Spine Journal · doi:10.1007/s00586-006-1072-1 · Cited by 2,594
Freynhagen, R., Baron, R., Gockel, U., & Tölle, T. R. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x132488 · Cited by 2,280 · cited 1×
“…drugs shown to be effective in preclinical models of neuropathic pain fail in clinical studies, either due to lack of tolerability or testing in heterogeneous groups of patients, highlighting the need for careful selection of patient subgroups in trials of potential neuropathic pain drug therapies.”
BackgroundSelf-citationEFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Self-citation
Cited by
Reframing chronic pain as a disease, not a symptom: rationale and implications for pain management
Clauw, D. J., Essex, M. N., Pitman, V., & Jones, K. D. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1574403 · Cited by 256
Shanthanna, H., Gilron, I., Rajarathinam, M., AlAmri, R., Kamath, S., Thabane, L., Devereaux, P. J., & Bhandari, M. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002369 · Cited by 177
Langlois, P., Perrochon, A., David, R., Rainville, P., Wood, C., Vanhaudenhuyse, A., Pageaux, B., Ounajim, A., Lavallière, M., Debarnot, U., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104591 · Cited by 94
A Comprehensive Review of Over the Counter Treatment for Chronic Low Back Pain
Peck, J., Urits, I., Peoples, S., Foster, L., Malla, A., Berger, A. A., Cornett, E. M., Kassem, H., Herman, J., Kaye, A. D., et al. (2021) · Pain and Therapy · doi:10.1007/s40122-020-00209-w · Cited by 65
Ashina, S., Lipton, R. B., Bendtsen, L., Hajiyeva, N., Buse, D. C., Lyngberg, A. C., & Jensen, R. (2018) · European Journal of Pain · doi:10.1002/ejp.1176 · Cited by 56
Metadata
- Authors
- Baron, R., Binder, A., Attal, N., Casale, R., Dickenson, A. H., & Treede, R.
- Venue
- European Journal of Pain
- Publisher
- Wiley
- Published
- 2016-03-02
- Volume
- 20
- Issue
- 6
- Pages
- 861-873
- ISSN
- 1090-3801 (ISSN-L)
- 1532-2149
- OpenAlex
- W2291450076
- Cited by
- 270
- References
- 81
- FWCI
- 16.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuropathic low back pain in clinical practice. https://app.cochat.ai/papers/10.1002/ejp.838
- The paper
- Baron, R., Binder, A., Attal, N., Casale, R., Dickenson, A. H., & Treede, R. (2016). Neuropathic low back pain in clinical practice. European Journal of Pain. https://doi.org/10.1002/ejp.838
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.